Leading with AI

AI Innovation at the Core of What We Do

Ehave transforms clinically validated, game‑based therapeutics into a diverse portfolio of AI‑native platforms. From evidence‑driven health solutions to enterprise SaaS, we scale technology that reduces friction, increases clarity, and expands human potential.

AI Innovation Video
Ehave (EHVVF) | +0.0023 (1.86%) SEC 20-F filed May 2025 OTC Tier: Current Market Cap: $42.7M

Our Story

From Vision to Innovation in AI and Therapeutics

2017
Leadership Established

and clinical strategy defined

2020
MegaTeam secures

FDA pathway for ADHD assessment and treatment

2025
Internal AI research program

launched to explore large‑language‑model infrastructure

2025
Growth milestone

acquisition of AIHeadhunter; stealth build of AI BioLab and AI HealthOps

Products & Assets

Our Proven Digital Therapeutics and AI-Driven Platforms

AI Headhunter Interface

AI Headhunter

The AI recruiting engine built for headhunters. A streamlined process that makes recruitment faster and more effective.

Key Features

  • Automatically discover and shortlist top-fit candidates using AI-driven search.
  • Rank candidates based on resume-job fit, skills match, and contextual insights.
  • Seamlessly push qualified candidates into your hiring pipeline.
Learn More About AI Headhunter

Future Pipeline

Driving Tomorrow's Innovations with AI-Powered Solutions

AI BioLab
GENERATIVE BIOLOGY
In R&D

Cloud robotics meets generative biology. We are prototyping automated wet-lab workflows, molecule design, assay setup, and data capture. All orchestrated by large-scale models.

AI Headhunter
TALENT DISCOVERY
Live

Automates high-ticket executive search with smart ranking and outreach. Delivers faster placements and higher margins for recruiters.

AI HealthOps
LLM wrappers for industry
Concept

Streamlining health-plan operations. From real-time claims review to invoice reconciliation, this platform aims to cut administrative waste across payers and TPAs.

AI Core

NLP + ML Models

Investor Center

Your Gateway to Transparent and Timely Investor Information

SEC Filings

20-F : Periodic Financial Reports

May 15, 2025

View

6-K : Corporate Changes...

August 17, 2024

View

6-K : Corporate Changes & Voting Matters

May 12, 2024

View

20-F/A : Periodic Financial Reports

March25, 2024

View

6-K : Corporate Changes & Voting Matters

January 14, 2024

View

Press Releases

AIBotics Targets in Q2 2025 Launch for Phill, the world's first...

April 28, 2025

Read

AIBotics Signs Agreement to Develop UI/UX for Phill Robot, Its...

April 15, 2025

Read

Mycotopia Therapies Inc. Announces Name...

March 22, 2025

Read

$40 Million Transaction: AIBiotics Signs Letter of Intent...

February 15, 2025

Read

Investor Relations Hub

Our Investor Relations hub puts everything in one place like live EHVVF stock quotes, SEC filings, press releases, corporate governance documents, and downloadable resources. It's updated in real time so investors can track our progress with confidence.

Our Leadership

Ehave is assembling a
focused leadership team.

UPDATES COMING SOON